These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 37375013)

  • 1. Eradication of Drug-Tolerant
    Lanni A; Iacobino A; Fattorini L; Giannoni F
    Microorganisms; 2023 Jun; 11(6):. PubMed ID: 37375013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting tuberculosis by drugs targeting nonreplicating
    Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
    Int J Mycobacteriol; 2017; 6(3):213-221. PubMed ID: 28776518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting dormant bacilli to fight tuberculosis.
    Fattorini L; Piccaro G; Mustazzolu A; Giannoni F
    Mediterr J Hematol Infect Dis; 2013 Nov; 5(1):e2013072. PubMed ID: 24363887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum.
    Sarathy JP; Xie M; Jones RM; Chang A; Osiecki P; Weiner D; Tsao WS; Dougher M; Blanc L; Fotouhi N; Via LE; Barry CE; De Vlaminck I; Sherman DR; Dartois VA
    mBio; 2023 Apr; 14(2):e0059823. PubMed ID: 37017524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of drugs against dormant Mycobacterium tuberculosis.
    Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S94-S95. PubMed ID: 28043638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extreme Drug Tolerance of Mycobacterium tuberculosis in Caseum.
    Sarathy JP; Via LE; Weiner D; Blanc L; Boshoff H; Eugenin EA; Barry CE; Dartois VA
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in
    Irwin SM; Prideaux B; Lyon ER; Zimmerman MD; Brooks EJ; Schrupp CA; Chen C; Reichlen MJ; Asay BC; Voskuil MI; Nuermberger EL; Andries K; Lyons MA; Dartois V; Lenaerts AJ
    ACS Infect Dis; 2016 Apr; 2(4):251-267. PubMed ID: 27227164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro potency of 2-(((2-hydroxyphenyl)amino)methylene)-5,5-dimethylcyclohexane-1,3-dione against drug-resistant and non-replicating persisters of Mycobacterium tuberculosis.
    Rather MA; Bhat ZS; Lone AM; Maqbool M; Bhat BA; Ahmad Z
    J Glob Antimicrob Resist; 2021 Jun; 25():202-208. PubMed ID: 33789204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis.
    Lanoix JP; Lenaerts AJ; Nuermberger EL
    Dis Model Mech; 2015 Jun; 8(6):603-10. PubMed ID: 26035868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caseum: a Niche for Mycobacterium tuberculosis Drug-Tolerant Persisters.
    Sarathy JP; Dartois V
    Clin Microbiol Rev; 2020 Jun; 33(3):. PubMed ID: 32238365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal models.
    Ahmad Z; Fraig MM; Pinn ML; Tyagi S; Nuermberger EL; Grosset JH; Karakousis PC
    J Antimicrob Chemother; 2011 Jul; 66(7):1560-6. PubMed ID: 21602551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial multiomic profiling reveals the novel polarization of foamy macrophages within necrotic granulomatous lesions developed in lungs of C3HeB/FeJ mice infected with
    Seto S; Nakamura H; Guo TC; Hikichi H; Wakabayashi K; Miyabayashi A; Nagata T; Hijikata M; Keicho N
    Front Cell Infect Microbiol; 2022; 12():968543. PubMed ID: 36237431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The search for new sterilizing anti-tuberculosis drugs.
    Mitchison DA
    Front Biosci; 2004 May; 9():1059-72. PubMed ID: 14977529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.
    Walter ND; Moore CM; Kayigire XA; Dide-Agossou C; Worodria W; Huang L; Everett CK; Schoolnik GS; Nahid P; Davis JL
    BMC Infect Dis; 2018 Jul; 18(1):293. PubMed ID: 29970012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum.
    Lanoix JP; Ioerger T; Ormond A; Kaya F; Sacchettini J; Dartois V; Nuermberger E
    Antimicrob Agents Chemother; 2016 Feb; 60(2):735-43. PubMed ID: 26574016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bedaquiline kills persistent Mycobacterium tuberculosis with no disease relapse: an in vivo model of a potential cure.
    Hu Y; Pertinez H; Liu Y; Davies G; Coates A
    J Antimicrob Chemother; 2019 Jun; 74(6):1627-1633. PubMed ID: 30789209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.
    Lanoix JP; Betoudji F; Nuermberger E
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1091-6. PubMed ID: 26643352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the Efficacy of New Anti-Tuberculosis Drugs.
    Mitchison DA; Davies GR
    Open Infect Dis J; 2008 Dec; 2():59-76. PubMed ID: 23814629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in
    Eoh H; Liu R; Lim J; Lee JJ; Sell P
    Front Cell Infect Microbiol; 2022; 12():958240. PubMed ID: 36072228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.